fda warning letters glp-1 september 2025 news issued 30 to telehealth companies for false and misleading claims about compounded products. This marks the second round of enforcement action since the agency's crackdown on misleading pharmaceutical ads Moderna, Prime Medicine, UnitedHealth: Readout

Concerns the FDA has flagged for this category generally - not specific to VivioMD - include: Dosing errors and confusion between milliliters, milligrams, and units in compounded injectable semaglutide Products sold as "semaglutide" that may actually contain salt forms such as semaglutide sodium or semaglutide acetate, which differ from the FDA-approved active ingredient and haven't been evaluated for safety or effectiveness Improper storage and shipping conditions for compounded injectables Fraudulent labels and doses beyond approved-label schedules Underreported adverse events across the compounded-GLP-1 category The FDA recommends that compounded drugs be used only for patients whose medical needs cannot be met by an FDA-approved drug - not as a default lower-cost substitute

Sensor protein was eluted with elution buffer containing 20 mM Tris-Cl and 250 mM imidazole (pH 7.4)

Benefits Skin Appearance As a strong antioxidant, it may help maintain healthy skin tone and appearance

PlexusDx's compounded semaglutide at $189/month represents a 85% reduction compared to brand retail costs, without sacrificing pharmaceutical quality or clinical efficacy

The package landed less than 24 hours after the shipping label was created, which is one of the fastest delivery windows we have measured